Pentetic Acid
CAS 67-43-6
Pentetic Acid (CAS 67-43-6) is a Phase 4 pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 21271.188588235294 nM | 34 | - |
| - | Potency | 13948.382500000002 nM | 32 | - |
| - | IC50 | 19500.810555555556 nM | 17 | - |
| - | MIC | 72 ug.mL-1 | 5 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Pentetic Acid | 3690 | SU | MTHSPL |
| PENTETIC ACID | 3690 | SU | MTHSPL |
| pentetic acid | 3690 | SU | MTHSPL |
| pentetic acid | 3690 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Pentetic Acid used for in pharmaceutical contexts?
Pentetic Acid (CAS 67-43-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Pentetic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Pentetic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Pentetic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for PENTETIC ACID with EU status "permitted".
What clinical phase is Pentetic Acid in?
Pentetic Acid is rendered with ChEMBL max phase 4 (approved).